inVentiv Health acquires Kazaam Interactive

Wednesday, June 6, 2012 09:10 AM

inVentiv Health, a global provider of clinical, commercial and consulting services to the healthcare industry, has acquired Kazaam Interactive, a Newton, Penn.-based full-service digital marketing agency offering digital strategy and solutions healthcare agencies and brands.

Kazaam Interactive will become part of inVentiv Health Communications, the public relations and advertising group within inVentiv's commercial segment. The acquisition will broaden inVentiv's ability to provide clients with comprehensive digital solutions from strategy through execution and will augment its digital expertise across multiple businesses.

"Demand for digital and social media solutions has expanded rapidly among our clients as physicians, patients and payers have grown more technically savvy," said Paul Meister, CEO of inVentiv Health. "Kazaam Interactive helps us to meet this growing demand with digitally-based programs that have been proven to deliver value. The combination of Kazaam's cutting-edge technology with inVentiv Commercial's broad expertise in healthcare PR and communication will result in fully-integrated and powerful solutions for our clients."

The acquisition of Kazaam Interactive will be fully funded with equity from funds affiliated with Thomas H. Lee Partners, L.P. (THL) and other existing stockholders.  THL, along with Liberty Lane IH and other co-investors, acquired inVentiv in August 2010.

"inVentiv is well-positioned to capture additional market share through its range of products and services. THL's equity funding for the Kazaam acquisition reinforces our commitment to working with the senior leadership team at inVentiv to strengthen its position,” said Todd Abbrecht, managing director of THL. “We will continue to work closely with the company to develop additional opportunities to maximize the global market opportunity for their expanded service offering."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs